Company is active
Event Year: 2025
Company is active
Event Year: 2025
Play Health is developing a comprehensive perimenopause care platform designed to empower women and their healthcare providers with the resources necessary for effective and rapid symptom relief. Founded by Andrea Mazzocchi, PhD, and Ian Miller, seasoned technical entrepreneurs with prior Y Combinator experience, including a successful exit and involvement with a unicorn company, Play Health addresses a significant and underserved market. Over 30 million women in the United States are currently navigating perimenopause, collectively spending over $15 billion annually on managing associated symptoms. However, many receive only generalized solutions and struggle to find lasting relief.
Play Health aims to deliver evidence-based perimenopause care through strategic partnerships with medical practices, employers, and health benefits programs. The platform integrates personalized data related to symptoms, medications, and lifestyle factors to generate AI-driven insights and clinical protocols, enabling providers to offer specialized and tailored care. Each clinical interaction contributes to a growing longitudinal dataset, facilitating improved patient outcomes, deeper insights for providers, and potential expansion into broader women's health applications. This data-driven approach also creates opportunities for collaboration with pharmaceutical and biotechnology companies focused on developing therapeutics and diagnostics for women's health.
Play Health is developing a comprehensive perimenopause care platform designed to empower women and their healthcare providers with the resources necessary for effective and rapid symptom relief. Founded by Andrea Mazzocchi, PhD, and Ian Miller, seasoned technical entrepreneurs with prior Y Combinator experience, including a successful exit and involvement with a unicorn company, Play Health addresses a significant and underserved market. Over 30 million women in the United States are currently navigating perimenopause, collectively spending over $15 billion annually on managing associated symptoms. However, many receive only generalized solutions and struggle to find lasting relief.
Play Health aims to deliver evidence-based perimenopause care through strategic partnerships with medical practices, employers, and health benefits programs. The platform integrates personalized data related to symptoms, medications, and lifestyle factors to generate AI-driven insights and clinical protocols, enabling providers to offer specialized and tailored care. Each clinical interaction contributes to a growing longitudinal dataset, facilitating improved patient outcomes, deeper insights for providers, and potential expansion into broader women's health applications. This data-driven approach also creates opportunities for collaboration with pharmaceutical and biotechnology companies focused on developing therapeutics and diagnostics for women's health.
Total Raised: Unknown (Y Combinator backed)
Last Round: Fall 2025
Total Raised: Unknown (Y Combinator backed)
Last Round: Fall 2025
Healthcare
Healthcare
Healthcare
Healthcare
Team size: 4
Hiring: No
Team size: 4
Hiring: No